Hm Payson & CO Repligen Corp Transaction History

Hm Payson & CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $15,635 - $25,022	-97 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$247.59 - $304.47 $24,016 - $29,533	97 New	97 $26,000
Q2 2021 Aug 17, 2021	SELL	$165.87 - $220.95 $34,832 - $46,399	-210 Closed	0 $0
Q4 2020 Mar 10, 2021	SELL	$148.08 - $206.57 $8,588 - $11,981	-58 Reduced 21.64%	210 $40,000
Q3 2020 Dec 21, 2020	BUY	$122.51 - $158.27 $32,832 - $42,416	268 New	268 $40,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

Stay updated on Hm Payson & CO with notifications on news.